Dr. Clifford Reid
Dr. Clifford Reid, chairman, president and chief executive officer of Complete Genomics, has 25 years of
experience in startup and growth companies managing the commercialization of innovative, unstructured data
management technologies. In 1995, he was the founding chairman and chief executive officer of Eloquent,
Inc., a digital video communications company that he took public in 2000 (NASDAQ: ELOQ) and sold it in
2003. In 1988, he was the founding vice president of product development at Verity (NASDAQ: VRTY), an
enterprise text search engine company that was recently sold to Autonomy for $500M. Cliff earned a B.S.
in physics from the Massachusetts Institute of Technology (MIT), an M.B.A. from the Harvard Business
School and a Ph.D. in management science and engineering (MSE) from Stanford University.
Ajay Bansal
Ajay Bansal joined Complete Genomics in May 2010 as chief financial officer. Bansal has more than 20 years
of experience in the biotechnology and pharmaceutical industry in corporate finance, corporate and business
development, strategic planning, and commercial operations. Prior to joining Complete Genomics, Bansal
served as executive vice president, corporate development and chief financial officer at Lexicon
Pharmaceuticals. Before joining Lexicon, he was chief financial officer and executive vice president of
corporate and business development for Tercica, Inc., which was acquired by Ipsen in 2008. From February
2003 to January 2006, Bansal was chief financial officer of Nektar Therapeutics. From July 2002 until
joining Nektar, he was director of operations analysis at Capital One Financial and, from August 1998 to
June 2002, he was with Mehta Partners LLC, a financial advisory firm where he was named partner in January
2000. Before joining Mehta Partners, Bansal spent more than 10 years in product management and strategy
roles at Novartis AG and as a management consultant with Arthur D. Little, Inc., McKinsey & Company, Inc.
and ZS Associates. He received his B.S. in mechanical engineering from the Indian Institute of Technology
in New Delhi, India, and both his M.S. in operations research and M.B.A. from Northwestern University.
Dr. Radoje Drmanac
Dr. Radoje (Rade) Drmanac, chief scientific officer of Complete Genomics, is one of the leading research scientists
in the field of DNA sequencing-by-hybridization (SBH). In 1994, he co-founded Hyseq (now Nuvelo, NASDAQ: NUVO)
where, as chief scientific officer, he led the effort to discover and patent thousands of genes which now form
the basis of Nuvelo’s drug development pipeline. Prior to Hyseq, Rade was a group leader at Argonne National Labs
from 1991 to 1994 as part of the Department of Energy’s Human Genome Project. He completed his postdoctoral studies
in 1990 in Hans Lehrach’s group at the Imperial Cancer Research Fund in London. He earned his Ph.D. in molecular
biology for the conception and pioneering development of SBH technology from Belgrade University, where he also
received B.S. and M.S. degrees in molecular biology.
Mark Sutherland
Mark J. Sutherland has served as our senior vice president of Business Development since March 2010. From October
2008 to November 2009, Mr. Sutherland served as Senior Vice President of Business Development at GenVault Corporation,
a DNA storage company. Beginning in August 1988, Mr. Sutherland served for 17 years in roles of increasing
responsibility at Molecular Dynamics and its successor companies, Amersham Biosciences and GE Healthcare. Mr.
Sutherland served as Vice President of Genomics at Amersham from 1998 to 2001 and as VP, Strategic Alliances at
Amersham and for the Discovery Systems business of GE Healthcare from 2001 to 2005. Mr. Sutherland received a B.S. in
Chemistry with Honors from Stanford University.
John Curson
John Curson, senior vice president of financial operations of Complete Genomics Inc., has more than 25 years of
experience in senior financial management positions with both venture-funded startup's and with public
companies. John has extensive experience in public companies, and served as the chief financial officer
during the initial and secondary public offerings for Eloquent Inc., RasterOps Inc. and Truevision
Inc.; all of which are NASDAQ listed public companies in the high-tech arena. John also managed the successful
acquisitions of Eloquent and Truevision by public companies. Prior to his chief financial officer
positions, John was vice president of finance for DataProducts, the world’s largest publicly-traded
computer printer company at the time. John is a member of the Silicon Valley Bank CFO Advisory Board.
John earned an M.B.A. from the Anderson School of Business at the University of California, Los Angeles.
He also earned an M.A. in operations research and economics and a B.Eng. in mechanical engineering from
the University of Leeds, UK.
Bruce Martin
Bruce Martin, senior vice president of product development at Complete Genomics, has 20 years of experience designing and developing
ground-breaking software technologies. Most recently, he was vice president of product strategy at PSS Systems. He also
served as chief technical officer at Openwave (NASDAQ: OPWV). During his 10 years at OpenWave he led product management,
engineering and business unit teams, and he participated in the development of pioneering mobile software applications.
Earlier in his career, he was an engineering manager in the Java development group at Sun Microsystems (NASDAQ: SUNW)
and helped shape this major technology. He earned a B.S. in computer science and electrical engineering from the University
of California at Davis.
Dr. Dennis Ballinger
Dr. Dennis Ballinger, vice president of genomics at Complete Genomics, has more than 20 years of genetics research
experience in both academic and industrial settings covering model organism genetics, biology and biochemistry,
human genetics and functional genomics. He has extensive experience managing collaborations with biotech and
pharmaceutical companies as well as non-profit organizations. Most recently, he served as vice president of
genomics at Perlegen Sciences. Prior to Perlegen, Dennis served as director of cardiovascular disease research at
Myriad Genetics, senior director of functional genomics at Hyseq and director of software product development at
Ingenuity Systems. Prior to this work in biotechnology companies, he was an assistant professor at the
Sloan-Kettering Institute for five years. Dennis obtained a Ph.D. in cellular and developmental biology from the
Massachusetts Institute of Technology (MIT) before completing his postdoctoral training at the California
Institute of Technology.
Dr. Bill Banyai
Dr. Bill Banyai, vice president of hardware at Complete Genomics, has 20 years of experience developing advanced
optical instruments. He was the founding chief technical officer of Glimmerglass Networks, an optical networking
company, and the chief technologist of Silicon Light Machines, a high-resolution display company (acquired by Cypress
Semiconductor). He served as a staff physicist at the Lawrence Livermore National Lab, a research engineer at Stanford
University’s Ginzton Laboratory and a research scientist at the Sandia National Lab’s Compound Semiconductor Research
Facility. He earned a B.S. in physics from the University of Michigan, an M.S. in electrical science from the University
of Michigan, an Engineer of Electrical Engineering from University of Southern California (USC), and a Ph.D. in optical
sciences from the University of Arizona.
Dr. Alan Dow
Dr. Alan Dow, vice president of intellectual property and legal affairs at Complete Genomics, has extensive
experience developing and managing intellectual property portfolios and negotiating complex corporate transactions
in the biotechnology and pharmaceutical sectors. Prior to joining Complete Genomics, he worked as an attorney in
private practice specializing in patent prosecution and intellectual property-related transactions. Alan also served
as vice president and general counsel at Vical Incorporated, and in other positions in law firms and corporations.
He earned a Ph.D. in genetics from Harvard University and a J.D. from Stanford Law School.
Jennifer Turcotte
Jennifer Turcotte, vice president of marketing at Complete Genomics, has more than 15 years of technology and biotechnology
marketing and product management experience with both venture-funded startups and public companies. Jennifer directs all
product management and marketing activities at Complete Genomics including product requirements, product marketing, market
entry strategy, communications, branding and public relations. She has held senior product marketing positions at SAP,
Siperian, Ariba and BEA. Jennifer earned a B.Eng. in mechanical engineering from Carleton University in Ottawa, Canada.
Aaron Solomon
Aaron Solomon, vice president of business development at Complete Genomics, has more than 20 years of experience in sales, marketing and business development in the life sciences marketplace, including at companies such as Incyte, ParAllele and Affymetrix. At ParAllele, Aaron led sales and business development efforts for this venture-backed company which culminated in its acquisition by Affymetrix. At Affymetrix, Aaron was responsible for the Industrial Sales team where he developed programs for biomarker discovery and validation. Most recently, Aaron was Vice President of Business Development for Tethys Bioscience. He holds a B.S. in Biological Sciences from U.C. Irvine.
Ken Prokuski
Ken Prokuski, vice president of program management at Complete Genomics, has extensive experience leading all phases of operations across several high technology areas including life science and capital equipment for the disk drive, semiconductor and communications markets. Prior to joining Complete Genomics, Ken served as senior director manufacturing operations at Applied Biosystems where most recently led the implementation of work class lean and process excellence techniques across all global operations. He has extensive multisite experience in leading manufacturing and development operations. Prior to Applied Biosystems Ken held leadership positions at Airco Coating Technology, Toshiba America, Millipore, and Motorola. He earned a B.A. from Northeastern Illinois University and an Executive MBA from Golden Gate University.
Top of page